Dynavax Statistics

Share Statistics

Dynavax has 120.08M shares outstanding. The number of shares has increased by -8.37% in one year.

Shares Outstanding	120.08M
Shares Change (YoY)	-8.37%
Shares Change (QoQ)	-3.22%
Owned by Institutions (%)	99.99%
Shares Floating	111.72M
Failed to Deliver (FTD) Shares	25,871
FTD / Avg. Volume	1.51%

Short Selling Information

The latest short interest is 15.16M, so 12.62% of the outstanding shares have been sold short.

Short Interest	15.16M
Short % of Shares Out	12.62%
Short % of Float	18.79%
Short Ratio (days to cover)	8.89

Valuation Ratios

The PE ratio is 60.81 and the forward PE ratio is 19.46. Dynavax's PEG ratio is -0.12.

PE Ratio	60.81
Forward PE	19.46
PS Ratio	5.99
Forward PS	3.1
PB Ratio	2.78
P/FCF Ratio	27.6
PEG Ratio	-0.12

Financial Ratio History

Enterprise Valuation

Dynavax has an Enterprise Value (EV) of 1.82B.

EV / Sales	6.56
EV / EBITDA	39.81
EV / EBIT	27.35
EV / FCF	30.24

Financial Position

The company has a current ratio of 10.8, with a Debt / Equity ratio of 0.43.

Current Ratio	10.8
Quick Ratio	9.91
Debt / Equity	0.43
Debt / EBITDA	5.57
Debt / FCF	4.23
Interest Coverage	-0.61

Financial Efficiency

Return on Equity is 4.58% and Return on Invested Capital is -0.4%.

Return on Equity	4.58%
Return on Assets	2.77%
Return on Invested Capital	-0.4%
Revenue Per Employee	$684.56K
Profits Per Employee	$67.43K
Employee Count	405
Asset Turnover	0.28
Inventory Turnover	0.71

Taxes

Income Tax	3.55M
Effective Tax Rate	11.49%

Stock Price Statistics

The stock price has increased by -3.94% in the last 52 weeks. The beta is 1.09, so Dynavax's price volatility has been higher than the market average.

Beta	1.09
52-Week Price Change	-3.94%
50-Day Moving Average	10.48
200-Day Moving Average	11.86
Relative Strength Index (RSI)	39.41
Average Volume (20 Days)	1,716,035

Income Statement

In the last 12 months, Dynavax had revenue of 277.25M and earned 27.31M in profits. Earnings per share was 0.21.

Revenue	277.25M
Gross Profit	227.8M
Operating Income	-4.12M
Net Income	27.31M
EBITDA	45.7M
EBIT	37.65M
Earnings Per Share (EPS)	0.21

Full Income Statement

Balance Sheet

The company has 95.88M in cash and 254.42M in debt, giving a net cash position of -158.53M.

Cash & Cash Equivalents	95.88M
Total Debt	254.42M
Net Cash	-158.53M
Retained Earnings	-903.27M
Total Assets	945.93M
Working Capital	747.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 66.51M and capital expenditures -6.35M, giving a free cash flow of 60.16M.

Operating Cash Flow	66.51M
Capital Expenditures	-6.35M
Free Cash Flow	60.16M
FCF Per Share	0.46

Full Cash Flow Statement

Margins

Gross margin is 82.17%, with operating and profit margins of -1.49% and 9.85%.

Gross Margin	82.17%
Operating Margin	-1.49%
Pretax Margin	11.13%
Profit Margin	9.85%
EBITDA Margin	16.48%
EBIT Margin	-1.49%
FCF Margin	21.7%

Dividends & Yields

DVAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	1.64%
FCF Yield	3.62%

Dividend Details

Analyst Forecast

The average price target for DVAX is $32, which is 205.6% higher than the current price. The consensus rating is "Buy".

Price Target	$32
Price Target Difference	205.6%
Analyst Consensus	Buy
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	4.66
Graham Upside	-55.49%

Stock Splits

The last stock split was on Nov 10, 2014. It was a backward split with a ratio of 1:10.

Last Split Date	Nov 10, 2014
Split Type	backward
Split Ratio	1:10

Scores

Altman Z-Score	1.49
Piotroski F-Score	5

Dynavax Technologies Corp... (DVAX)